UK markets closed
NIKKEI 225
26,423.47 +269.66 (+1.03%) HANG SENG
21,853.07 +22.72 (+0.10%) CRUDE OIL
99.55 -8.88 (-8.19%) GOLD FUTURES
1,763.80 -37.70 (-2.09%) DOW
30,967.82 -129.44 (-0.42%) BTC-GBP
16,973.44 +349.21 (+2.10%)
Esperion Therapeutics, Inc. (ESPR)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 6.45 |
| Open | 6.37 |
| Bid | 6.98 x 1300 |
| Ask | 7.10 x 1300 |
| Day's range | 6.24 - 7.03 |
| 52-week range | 3.28 - 20.75 |
| Volume | |
| Avg. volume | 1,208,203 |
| Market cap | 440.416M |
| Beta (5Y monthly) | 0.42 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -6.24 |
| Earnings date | 01 Aug 2022 - 05 Aug 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 10.80 |
- Zacks
Enanta Pharmaceuticals (ENTA) Stock Jumps 10.1%: Will It Continue to Soar?
Enanta Pharmaceuticals (ENTA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
- Simply Wall St.
Is Esperion Therapeutics, Inc. (NASDAQ:ESPR) Popular Amongst Institutions?
The big shareholder groups in Esperion Therapeutics, Inc. ( NASDAQ:ESPR ) have power over the company. Insiders often...
- Zacks
Esperion Therapeutics (ESPR) Down 15.1% Since Last Earnings Report: Can It Rebound?
Esperion Therapeutics (ESPR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
© 2022 Yahoo. All rights reserved.
